Viewing Study NCT00276159

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:35 PM
Ignite Modification Date: 2026-01-31 @ 5:50 PM
Study NCT ID: NCT00276159
Status: TERMINATED
Last Update Posted: 2019-09-04
First Post: 2006-01-11
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Immune Response Modifier in the Treatment of Hematologic Malignancies
Sponsor: Masonic Cancer Center, University of Minnesota
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia View
None Acute Myeloid Leukemia View
None Non-Hodgkin's Lymphoma View
None Hodgkin's Lymphoma View
None Multiple Myeloma View
None Chronic Lymphocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Leukemia View
None Lymphoma View
None Myeloma View
None Hematology View
None 852A View
None IRM View
None Oncology View